Exploring Advancements in Oncology with AstraZeneca’s Dr. Susan Galbraith

Thought Leader:

Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca

April 6, 2021      

PharmaVOICE sat down with Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca, who disclosed her personal career journey with oncology and drug development as she works to improve patients’ lives.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK